Last reviewed · How we verify
JYP0035 Experimental Drug Treatment — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
JYP0035 Experimental Drug Treatment (JYP0035 Experimental Drug Treatment) — Chengdu JOYO pharma Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| JYP0035 Experimental Drug Treatment TARGET | JYP0035 Experimental Drug Treatment | Chengdu JOYO pharma Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- JYP0035 Experimental Drug Treatment CI watch — RSS
- JYP0035 Experimental Drug Treatment CI watch — Atom
- JYP0035 Experimental Drug Treatment CI watch — JSON
- JYP0035 Experimental Drug Treatment alone — RSS
Cite this brief
Drug Landscape (2026). JYP0035 Experimental Drug Treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/jyp0035-experimental-drug-treatment. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab